Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jul 30;56(1):2001201.
doi: 10.1183/13993003.01201-2020. Print 2020 Jul.

Venous thromboembolism in SARS-CoV-2 patients: only a problem in ventilated ICU patients, or is there more to it?

Maarten Criel  1 , Maarten Falter  1 , Jasmien Jaeken  1 , Margaretha Van Kerrebroeck  1 , Isabelle Lefere  2 , Liesbeth Meylaerts  2 , Dieter Mesotten  3   4 , Margot Vander Laenen  4 , Tom Fivez  4 , Michiel Thomeer  1   3 , David Ruttens  5
Affiliations

Venous thromboembolism in SARS-CoV-2 patients: only a problem in ventilated ICU patients, or is there more to it?

Maarten Criel et al. Eur Respir J. .

Abstract

Insidious venous thromboembolism (VTE) is mainly a problem in ICU-ventilated SARS-CoV-2 patients, while patients in the general ward, treated with thromboprophylaxis (0.5 mg·kg−1), had a low incidence of insidious VTE https://bit.ly/2Yl8jft

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: M. Criel has nothing to disclose. Conflict of interest: M. Falter has nothing to disclose. Conflict of interest: J. Jaeken has nothing to disclose. Conflict of interest: M. Van Kerrebroeck has nothing to disclose. Conflict of interest: I. Lefere has nothing to disclose. Conflict of interest: L. Meylaerts has nothing to disclose. Conflict of interest: D. Mesotten has nothing to disclose. Conflict of interest: M. vander Laenen has nothing to disclose. Conflict of interest: T. Fivez has nothing to disclose. Conflict of interest: M. Thomeer has nothing to disclose. Conflict of interest: D. Ruttens has nothing to disclose.

Figures

FIGURE 1
FIGURE 1
Patient population. ICU: intensive care unit; VTE: venous thromboembolism.
See this image and copyright information in PMC

Comment in

References

    1. Spyropoulos AC, Anderson FA, FitzGerald G, et al. . Predictive and associative models to identify hospitalized medical patients at risk for VTE. Chest 2011; 140: 706–714. doi:10.1378/chest.10-1944 - DOI - PubMed
    1. Anderson FA. Jr, Spencer FA. Risk factors for venous thromboembolism. Circulation 2003; 107: 91–16. doi:10.1161/01.CIR.0000078469.07362.E6 - DOI - PubMed
    1. Tapson VF, Decousus H, Pini M, et al. . Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients. Chest 2007; 132: 936–945. doi:10.1378/chest.06-2993 - DOI - PubMed
    1. Cohen AT, Tapson VF, Bergmann J-F, et al. . Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet 2008; 371: 387–394. doi:10.1016/S0140-6736(08)60202-0 - DOI - PubMed
    1. Kaplan D, Casper TC, Elliot CG, et al. . VTE incidence and risk factors in patients with severe sepsis and septic shock. Chest 2015; 148: 1224–1230. doi:10.1378/chest.15-0287 - DOI - PMC - PubMed

LinkOut - more resources